Online registrations
|
08:15 - 08:55 |
Welcome note from MarketsandMarkets
|
08:55 - 09:00 |
Opening Remarks from the Chairman
Dr Pedro Estrela, Director of the Centre for Biosensors, Bioelectronics and Biodevices (C3Bio),Associate Professor, Department of Electronic & Electrical Engineering, University of Bath, University of Bath
|
09:00 - 09:10 |
PATHOGENS DETECTION NEEDS AT POINT OF CARE |
Biosensors and lab-on-chip devices for cancer diagnosis and management
Dr Pedro Estrela, Director of the Centre for Biosensors, Bioelectronics and Biodevices (C3Bio),Associate Professor, Department of Electronic & Electrical Engineering, University of Bath, University of Bath
|
09:10 - 09:40 |
The pros and cons of point of care testing for COVID-19 virus: virus, antigens and antibodies
Alan Wu, San Francisco General Hospital, USA, Clinical Chemistry and Toxicology
|
09:40 - 10:10 |
How the COVID-19 Exposes the Flaws of Current HealthTesting – Hypermobility & Microfluidics for Health 4.0 Tools for new Medicine
Dr. Ali Tinazli, Chief Commercial Officer , Fluxergy, USA
|
10:10 - 10:40 |
CLINICAL APPLICATIONS OF POINT-OF-CARE TOWARDS INFECTIOUS DISEASES |
Application of Point-Of-Care in disease outbreak
Nicola Hodges , Point of Care Coordinator , Royal United Hospitals Bath NHS Foundation Trust, UK
|
10:40 - 11:10 |
Critical needs of reagents and assay kits to fight COVID-19 and SARS-CoV-2 variants
Dr. Prajwal Paudel , Product Development Scientist , ACROBiosystems,USA
|
11:10 - 11:40 |
Blockchain-backed participatory research model for rapid customization of an open Lab on a Chip platform towards emerging challenges in point-of-care diagnostics
Jens Ducree, Professor of Microsystems in the School of Physical Sciences, Dublin City University (DCU)
|
11:40 - 12:10 |
Co-Diagnostics New Rapid PCR Point-of-Care and at Home Testing Platform to Detect Covid-19 and Other Diseases Using CoPrimer™ Technology
Dwight Egan, Chief Executive Officer, Co-Diagnostics, Inc
|
12:10 - 12:40 |
SARS-CoV-2 & Seasonal Influenza Lateral Flow Multiplex Assays For Point Of Care Or At Home Diagnostic Products
David Alan Zarling, Executive Chairman and Co-Founder, OptiSomix Incorporated
|
12:40 - 13:10 |
Closing remarks from the Chairman
|
13:10 - 13:15 |
One-to-One networking break| End of Day 1
|
13:15 - 13:15 |